GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Anbio Biotechnology NNNN · USD

Health Care · US listing · 🇺🇸 United States

Compare

4.08

+4.88%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Anbio Biotechnology and similar listings

Same market and sector, closest in size

Name Last closeMarket valueP/ENet marginYield Change
Anbio Biotechnology NNNN 4.08$179.1m25.274.1%— +4.88%
Kiniksa Pharmaceuticals International KNSA 98.76$7.80bn128.78.7%— +5.22%
NewAmsterdam Pharma Company NAMS 19.00$2.18bn—-905.7%— +0.53%
Dianthus Therapeutics DNTH 90.00$3.48bn—-7973.3%— +4.61%
ICU Medical ICUI 178.85$4.36bn5751.20.0%— +3.92%
ADMA Biologics ADMA 12.79$3.13bn17.528.8%— +0.47%
Brookdale Senior Living BKD 9.31$2.19bn—-8.4%— +3.33%
Telix Pharmaceuticals Limited TLX 9.89$3.35bn—-0.9%— +2.70%
LivaNova LIVN 92.61$5.05bn—-17.5%— +2.91%

Closes are in the currency each stock trades in. Blank figures mean we hold no company data for that listing yet.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.